News
-
-
COMMUNIQUÉ DE PRESSE
Spexis announces closing of sale of preclinical antibiotics program to Basilea
Spexis AG announces the closing of the sale of a preclinical antibiotics program to Basilea, which will pay up to CHF 2 million for the program. The program targets Gram-negative bacteria, including multidrug-resistant strains. The sale is part of Spexis' strategy to divest non-core programs and assets to focus on rare diseases and oncology -
-
-
COMMUNIQUÉ DE PRESSE
VENCORA UK Limited publishes provisional notice of the end result of the public tender offer for all publicly held registered shares in CREALOGIX Holding AG
VENCORA UK Limited publishes provisional notice of the end result of the public tender offer for all publicly held registered shares in CREALOGIX Holding AG. The participation of VENCORA UK Limited, its affiliates, and other persons acting in concert is 99.07% of the issued share capital and voting rights -
COMMUNIQUÉ DE PRESSE
VENCORA UK Limited publie l’annonce provisoire du résultat final de l’offre publique d’acquisition portant sur toutes les actions de CREALOGIX Holding AG en mains du public
VENCORA UK Limited publie l’annonce provisoire du résultat final de l’offre publique d’acquisition portant sur toutes les actions de CREALOGIX Holding AG en mains du public. L'annonce définitive du résultat final de l’offre devrait être publiée le 13 février 2024 -
COMMUNIQUÉ DE PRESSE
Successful finish to the year: Nemetschek Group clearly achieves its already raised targets for the financial year 2023
Nemetschek Group achieves 8.0% revenue growth to EUR 851.6 million and 30.3% EBITDA margin for the financial year 2023. Annual recurring revenue (ARR) grows by 26.7% to EUR 718.6 million, with 76.6% share of recurring revenues -
COMMUNIQUÉ DE PRESSE
Swiss Prime Site: Increase in operating results in the 2023 financial year
Swiss Prime Site AG reports increase in rental income by 4.3% and reduction in vacancies to record low of 4.0%. Operating results per share increase by +1.3% to CHF 4.05. Annual dividend proposal stable at CHF 3.40 -
-
